Your shopping cart is currently empty

Ribocil-C Racemate is the racemate of Ribocil-C, a highly selective inhibitor of bacterial riboflavin riboswitches that control the expression of de novo riboflavin (RF, vitamin B2) biosynthesis in Escherichia coli.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
| Description | Ribocil-C Racemate is the racemate of Ribocil-C, a highly selective inhibitor of bacterial riboflavin riboswitches that control the expression of de novo riboflavin (RF, vitamin B2) biosynthesis in Escherichia coli. |
| In vitro | Ribocil-C, a highly selective inhibitor of the flavin mononucleotide (FMN) riboswitch, effectively regulates the expression of de novo riboflavin (RF, vitamin B2) biosynthesis in Escherichia coli. It specifically targets dual FMN riboswitches to control both RF biosynthesis and uptake processes, critical for the growth and pathogenesis of Staphylococcus aureus. Additionally, Ribocil-C, a small-molecule synthetic FMN analog, binds the FMN riboswitch in various Gram-negative bacteria, including Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii. By inhibiting ribB expression and RF synthesis, it successfully halts bacterial proliferation [1] [2]. |
| In vivo | Treatment with higher doses of Ribocil-C (60 and 120 mg/kg) demonstrated a dose-dependent decrease in bacterial load, with reductions of 1.87 and 3.29 log10 [CFU per g spleen], respectively, compared to the sham-treated mice. No mortality or significant toxicity effects were observed [2]. |
| Molecular Weight | 419.5 |
| Formula | C21H21N7OS |
| Cas No. | 2309762-18-1 |
| Smiles | O=C1N=C(NC(=C1)C2=CC=CS2)C3CN(CC4=CN(C=N4)C=5N=CC=CN5)CCC3 |
| Relative Density. | 1.47 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 30 mg/mL (71.51 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 2 mg/mL (4.77 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.